Research ArticleArticle
Ten-year Followup of Infliximab Therapy in Rheumatoid Arthritis Patients with Severe, Longstanding Refractory Disease: A Cohort Study
Filip De Keyser, Joris De Kock, Hermine Leroi, Patrick Durez and René Westhovens
The Journal of Rheumatology June 2014, jrheum.131270; DOI: https://doi.org/10.3899/jrheum.131270
Filip De Keyser
Belgium From Department BVBA; Department of Rheumatology, of Rheumatology, Ghent University, Pôle deGhent; Recherche MSD en Rhumatologie, Université Catholique Institut de de Louvain Recherche and Expérimentale Cliniques Universitaires et Clinique, Saint-Luc, of Brussels; Development Skeletal and Biology Regeneration and Engineering KU Leuven; Research and Department Center, Department of Rheumatology, Supported University; Department F. De Keyser, by H. of an MD; Leroi, Rheumatology, University unrestricted J. MSD De Kock, Hospitals Belgium educational Pôle MD, de BVBA, Leuven, Department Recherche grant Brussels; Leuven, from of en Rheumatology, Rhumatologie, MSD Belgium. P. Durez, Belgium. MD, Ghent Institut de Recherche Expérimentale et Clinique, Université Catholique de Development Louvain PhD, Skeletal and Cliniques and Biology Regeneration and Universitaires Engineering KU Leuven; Saint-Luc; Research and Department R. Center, Westhovens, Department of MD, of Rheumatology, University Hospitals Leuven. Address 0K12, Department correspondence of Rheumatology, to Prof. De Keyser, De Pintelaan Ghent 185, University B-9000 Hospital Ghent, Belgium. E-mail: filip.dekeyser@ugent.be Accepted for publication March 26, 2014.
Joris De Kock
Belgium From Department BVBA; Department of Rheumatology, of Rheumatology, Ghent University, Pôle deGhent; Recherche MSD en Rhumatologie, Université Catholique Institut de de Louvain Recherche and Expérimentale Cliniques Universitaires et Clinique, Saint-Luc, of Brussels; Development Skeletal and Biology Regeneration and Engineering KU Leuven; Research and Department Center, Department of Rheumatology, Supported University; Department F. De Keyser, by H. of an MD; Leroi, Rheumatology, University unrestricted J. MSD De Kock, Hospitals Belgium educational Pôle MD, de BVBA, Leuven, Department Recherche grant Brussels; Leuven, from of en Rheumatology, Rhumatologie, MSD Belgium. P. Durez, Belgium. MD, Ghent Institut de Recherche Expérimentale et Clinique, Université Catholique de Development Louvain PhD, Skeletal and Cliniques and Biology Regeneration and Universitaires Engineering KU Leuven; Saint-Luc; Research and Department R. Center, Westhovens, Department of MD, of Rheumatology, University Hospitals Leuven. Address 0K12, Department correspondence of Rheumatology, to Prof. De Keyser, De Pintelaan Ghent 185, University B-9000 Hospital Ghent, Belgium. E-mail: filip.dekeyser@ugent.be Accepted for publication March 26, 2014.
Hermine Leroi
Belgium From Department BVBA; Department of Rheumatology, of Rheumatology, Ghent University, Pôle deGhent; Recherche MSD en Rhumatologie, Université Catholique Institut de de Louvain Recherche and Expérimentale Cliniques Universitaires et Clinique, Saint-Luc, of Brussels; Development Skeletal and Biology Regeneration and Engineering KU Leuven; Research and Department Center, Department of Rheumatology, Supported University; Department F. De Keyser, by H. of an MD; Leroi, Rheumatology, University unrestricted J. MSD De Kock, Hospitals Belgium educational Pôle MD, de BVBA, Leuven, Department Recherche grant Brussels; Leuven, from of en Rheumatology, Rhumatologie, MSD Belgium. P. Durez, Belgium. MD, Ghent Institut de Recherche Expérimentale et Clinique, Université Catholique de Development Louvain PhD, Skeletal and Cliniques and Biology Regeneration and Universitaires Engineering KU Leuven; Saint-Luc; Research and Department R. Center, Westhovens, Department of MD, of Rheumatology, University Hospitals Leuven. Address 0K12, Department correspondence of Rheumatology, to Prof. De Keyser, De Pintelaan Ghent 185, University B-9000 Hospital Ghent, Belgium. E-mail: filip.dekeyser@ugent.be Accepted for publication March 26, 2014.
Patrick Durez
Belgium From Department BVBA; Department of Rheumatology, of Rheumatology, Ghent University, Pôle deGhent; Recherche MSD en Rhumatologie, Université Catholique Institut de de Louvain Recherche and Expérimentale Cliniques Universitaires et Clinique, Saint-Luc, of Brussels; Development Skeletal and Biology Regeneration and Engineering KU Leuven; Research and Department Center, Department of Rheumatology, Supported University; Department F. De Keyser, by H. of an MD; Leroi, Rheumatology, University unrestricted J. MSD De Kock, Hospitals Belgium educational Pôle MD, de BVBA, Leuven, Department Recherche grant Brussels; Leuven, from of en Rheumatology, Rhumatologie, MSD Belgium. P. Durez, Belgium. MD, Ghent Institut de Recherche Expérimentale et Clinique, Université Catholique de Development Louvain PhD, Skeletal and Cliniques and Biology Regeneration and Universitaires Engineering KU Leuven; Saint-Luc; Research and Department R. Center, Westhovens, Department of MD, of Rheumatology, University Hospitals Leuven. Address 0K12, Department correspondence of Rheumatology, to Prof. De Keyser, De Pintelaan Ghent 185, University B-9000 Hospital Ghent, Belgium. E-mail: filip.dekeyser@ugent.be Accepted for publication March 26, 2014.
René Westhovens
Belgium From Department BVBA; Department of Rheumatology, of Rheumatology, Ghent University, Pôle deGhent; Recherche MSD en Rhumatologie, Université Catholique Institut de de Louvain Recherche and Expérimentale Cliniques Universitaires et Clinique, Saint-Luc, of Brussels; Development Skeletal and Biology Regeneration and Engineering KU Leuven; Research and Department Center, Department of Rheumatology, Supported University; Department F. De Keyser, by H. of an MD; Leroi, Rheumatology, University unrestricted J. MSD De Kock, Hospitals Belgium educational Pôle MD, de BVBA, Leuven, Department Recherche grant Brussels; Leuven, from of en Rheumatology, Rhumatologie, MSD Belgium. P. Durez, Belgium. MD, Ghent Institut de Recherche Expérimentale et Clinique, Université Catholique de Development Louvain PhD, Skeletal and Cliniques and Biology Regeneration and Universitaires Engineering KU Leuven; Saint-Luc; Research and Department R. Center, Westhovens, Department of MD, of Rheumatology, University Hospitals Leuven. Address 0K12, Department correspondence of Rheumatology, to Prof. De Keyser, De Pintelaan Ghent 185, University B-9000 Hospital Ghent, Belgium. E-mail: filip.dekeyser@ugent.be Accepted for publication March 26, 2014.
Roles: the Infliximab EAP Study Group
In this issue
The Journal of Rheumatology
Vol. 51, Issue 4
1 Apr 2024
Ten-year Followup of Infliximab Therapy in Rheumatoid Arthritis Patients with Severe, Longstanding Refractory Disease: A Cohort Study
Filip De Keyser, Joris De Kock, Hermine Leroi, Patrick Durez, René Westhovens
The Journal of Rheumatology Jun 2014, jrheum.131270; DOI: 10.3899/jrheum.131270